Infectious Diseases Institute, Makerere University College of Health Sciences, P.O.Box 22418, Kampala, Uganda.
School of Medicine, Makerere University College of Health Sciences, P.O.Box 7072, Kampala, Uganda.
BMC Public Health. 2018 Aug 22;18(1):1048. doi: 10.1186/s12889-018-5964-x.
The UNAIDS 90-90-90 strategy clearly stipulates that 90% of all people on antiretroviral therapy (ART) should have a suppressed viral load. Intensified adherence counselling (IAC) was recently recommended by WHO to improve viral suppression among ART-treated paediatric and adolescent clients with virological failure. This paper describes the implementation and outcomes of IAC in the first year of implementation in a public ART program, to inform strategic interventions to reach the "third 90" among children.
A retrospective chart review was conducted for all children aged 9 months to 19 years with HIV viral loads (VL) ≥ 1000 copies/ml at 15 public health facilities from June 2015-December 2016. Data on initial VL test results, IAC sessions, repeat VL test results, and ART regimen switch were abstracted and analysed for completion of IAC and viral suppression after IAC.
A total of 449 children had a detectable viral load above 1000 copies/ml, after an average of 3.5 years (SD 5.8) years of ART. 192 (43%) were 10-20 years of age, and 320 (71%) were receiving Nevirapine-based ART regimen. Out of 345 (77%) who completed the recommended three IAC sessions, 62 (23%) achieved viral suppression following IAC. The mean time from 1st to 3rd IAC session was 113 (SD 153) days and 172 (50%) of the children had completed the three sessions within 200 days.
Suppression rates were low among ART-treated children with virological failure that completed the recommended three IAC sessions. As we move towards having 90% of ART-treated children and adolescents achieve and maintain viral suppression, there is need to re-evaluate the implementation of IAC among children and adolescents to consider both psychosocial and biological factors such as resistance testing for those with multiple detectable viral loads.
艾滋病规划署的 90-90-90 战略明确规定,所有接受抗逆转录病毒治疗(ART)的患者中,有 90%的人病毒载量应得到抑制。世卫组织最近建议强化依从性咨询(IAC),以提高经抗病毒治疗的儿科和青少年患者中病毒学失败患者的病毒抑制率。本文描述了在一个公共艾滋病治疗项目中实施 IAC 的第一年的实施情况和结果,为实现儿童中“第三个 90”提供信息战略干预措施。
对所有在 2015 年 6 月至 2016 年 12 月期间在 15 个公共卫生机构就诊的 9 个月至 19 岁 HIV 病毒载量(VL)≥1000 拷贝/ml 的儿童进行回顾性图表审查。提取并分析了初始 VL 检测结果、IAC 会话、重复 VL 检测结果和 ART 方案转换的数据,以了解 IAC 的完成情况以及 IAC 后病毒抑制情况。
在接受平均 3.5 年(SD 5.8)ART 治疗后,共有 449 名儿童的病毒载量高于 1000 拷贝/ml。其中 192 名(43%)年龄为 10-20 岁,320 名(71%)正在接受奈韦拉平为基础的 ART 方案。在完成建议的三次 IAC 疗程的 345 名(77%)儿童中,有 62 名(23%)在 IAC 后实现了病毒抑制。从第一次到第三次 IAC 会话的平均时间为 113 天(SD 153),有 172 名(50%)儿童在 200 天内完成了三次会话。
在完成建议的三次 IAC 疗程的接受抗病毒治疗的病毒学失败儿童中,抑制率较低。随着我们努力使 90%的接受抗逆转录病毒治疗的儿童和青少年实现并维持病毒抑制,有必要重新评估儿童和青少年的 IAC 实施情况,考虑包括耐药性检测在内的社会心理和生物学因素,以解决多次检测到病毒载量的问题。